
Alfred Thomas Lane MD
Professor, Dermatology, Stanford University Medical Center
Join to view full profile
900 Blake Wilbur DrW0071Stanford, CA 94305
Phone+1 650-723-6105
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alfred Lane, MD is a board certified dermatologist in Stanford, California. He is currently licensed to practice medicine in California. He is a Professor at Stanford University Medical Center.
Education & Training
University of ColoradoResidency, Dermatology, 1979 - 1982
Children's Hospital Los AngelesResidency, Pediatrics, 1973 - 1976
Ohio State University College of MedicineClass of 1973
Certifications & Licensure
CA State Medical License 1974 - 2021
American Board of Dermatology Dermatology
American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 1 citationsMeasurement of skin adhesion in recessive dystrophic epidermolysis bullosa patients.J. Nazaroff, Martin A.C. Manoukian, M. Barriga, Alfred T. Lane, M.P. Marinkovich
Journal of the American Academy of Dermatology. 2021-08-01 - 32 citationsDiaper dermatitis prevalence and severity: Global perspective on the impact of caregiver behavior.Andrew N. Carr, Thomas G. DeWitt, Michael J. Cork, Lawrence F. Eichenfield, Regina Fölster-Holst
Pediatric Dermatology. 2020-01-01 - 169 citationsSafety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.Zurab Siprashvili, Ngon T. Nguyen, Emily S. Gorell, Kylie Loutit, Phuong Khuu
JAMA. 2016-11-01
Press Mentions
Gene Therapy Skin Grafts Promote Healing in Patients with Severe Genetic DiseaseJune 23rd, 2025
Stanford Medicine-Led Phase 3 Trial Shows Gene Therapy Skin Grafts Help Epidermolysis BullosaJune 18th, 2025
Stanford Expert Explains Breakthrough Skin Graft Treatment for Rare DiseaseApril 30th, 2025









